Report cover image

The World Market for Liquid Biopsy, 2023

Publisher Kalorama Information
Published Dec 01, 2022
Length 211 Pages
SKU # KLI17631872

Description

The World Market for Liquid Biopsy, 2023

Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the Liquid Biopsy Market now and in 2027. The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships.

Liquid biopsy is gaining acceptance each year. Even through the COVID-19 pandemic, announcements of new liquid biopsy products were made and studies conducted to assess the capability of these tests in clinical diagnostics uses. While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and limitations and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care.

This report, The World Liquid Biopsy Market, 2023, from Kalorama Information, contains up-to-date information and useful data points for business planning:

The Market for Liquid Biopsy by Region
  • North America
  • Europe
  • Asia
  • Rest of World
The Market for CTC-based Liquid Biopsy
  • Growth to 2027
The Market for ctDNA-based Liquid Biopsy
  • Growth to 2027
The Market for EV and Exosome-based Liquid Biopsy
  • Growth to 2027
The Market for Multi-Analyte-based Liquid Biopsy
  • Growth to 2027
The Market for Other Analytes Liquid Biopsy
  • Growth to 2027
Liquid Biopsy Market by Type of Cancer
  • Breast
  • Lung
  • Colorectal
  • Ovarian
  • Prostate
  • Pan-Cancer
  • Other Cancer
R&D: Selected ctDNA-based Liquid Biopsy Tests in Development

On the Market: Selected Market-Available CTC-based Liquid Biopsy Tests, 2021

On the Market: Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2021

Liquid biopsy testing has many potential applications in aspects of clinical oncology, including:
  • Early detection and diagnosis / screening
  • Alternative testing method when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown
  • Therapy personalization and monitoring – by molecular characterization of a patient’s disease, clinicians can select the optimal course of therapy and monitor efficacy over time, as well as quickly react to adjust therapy should treatment resistance arise
  • Disease monitoring – to observe disease progression, tumor evolution, residual disease, and early detection of recurrence
These applications, increasing acceptance, the use of liquid biopsy in combination with other technologies. This report contains market assessments for these application categories.

In addition, the report profiles key companies in the market, including:
  • Adaptive Biotechnologies
  • Agena Bioscience, Inc.
  • Angle, PLC
  • Aspira Women’s Health
  • Biocartis Group Nv
  • Biocept, Inc.
  • Biodesix
  • Cellmax Life
  • Circulogene
  • Diacarta, Inc.
  • Epic Sciences
  • Epigenomics AG
  • Exact Sciences
  • Exosome Diagnostics, Inc.
  • Foundation Medicine, Inc. (Roche)
  • Freenome, Inc.
  • Gilupi Gmbh
  • Grail (Illumina)
  • Guardant Health, Inc.
  • Hologic
  • Lunglife AI (Formerly Cynvenio Biosystems)
  • Menarini-Silicon Biosystems, SPA
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Neogenomics Laboratories, Inc.
  • Oncocyte Corporation
  • Oncodna S.A.
  • Personal Genome Diagnostics
  • Qiagen N.V.
  • Cell-Free DNA Technologies
  • Ctc Technologies
  • Exosome And Mirna Technologies
  • Resolution Biosciences (Agilent)
  • Roche Diagnostics
  • Sysmex-Inostics, Inc.
  • Tempus
  • Volitionrx

Table of Contents

211 Pages
    • Introduction
    • Liquid Biopsy Technologies
    • Industry Structure
    • Liquid Biopsy Market Revenues and Forecast
    • Introduction
    • Current Major Liquid Biopsy Technologies
    • Introduction
    • Advantages and Limitations of ctDNA in Liquid Biopsy
    • Current ctDNA-based Liquid Biopsy Tests
    • ctDNA-based Liquid Biopsy Tests in Development
    • Introduction
    • Challenges in the Development of CTC-based Liquid Biopsy Tests
    • CTC-based Liquid Biopsy Tests
    • Selected CTC-based Liquid Biopsy Tests in Development
    • Introduction
    • Liquid Biopsy Tests Based on Extracellular Vesicles / Other Analytes
    • Extracellular Vesicle/Other Analyte-based Liquid Biopsy Tests in Development
    • Introduction
    • Liquid Biopsy Tests Based on Multiple Analytes
    • Multiple Analyte-based Liquid Biopsy Tests in Development
    • Introduction
    • Liquid Biopsy Tests for Research Use Only
    • Introduction
    • Tiers of Competition
    • Competitive Factors
    • Significant Market Trends
    • Competitors No Longer in the Liquid Biopsy Market
    • Market Overview
    • Market Forecast
    • Circulating Tumor DNA
    • Circulating Tumor Cells
    • Extracellular Vesicles and Other Analytes
    • Multiple Analytes
    • Therapy Guidance and Monitoring
    • Diagnosis/Screening
    • Disease Prognosis
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Other Cancers
    • Pan-Cancer Tests
    • Companies in the Market
    • Adaptive Biotechnologies
    • Agena Bioscience, Inc.
    • ANGLE, plc
    • Aspira Women’s Health
    • Biocartis Group NV
    • Biocept, Inc.
    • Biodesix
    • CellMax Life
    • Circulogene
    • DiaCarta, Inc.
    • Epic Sciences
    • Epigenomics AG
    • Exact Sciences
    • Exosome Diagnostics, Inc.
    • Foundation Medicine, Inc. (Roche)
    • Freenome, Inc.
    • GILUPI GmbH
    • GRAIL (Illumina)
    • Guardant Health, Inc.
    • Hologic
    • LungLife AI (formerly Cynvenio Biosystems)
    • Menarini-Silicon Biosystems, Spa
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • NeoGenomics Laboratories, Inc.
    • Oncocyte Corporation
    • OncoDNA S.A.
    • Personal Genome Diagnostics
    • QIAGEN N.V.
    • Resolution Biosciences (Agilent)
    • Roche Diagnostics
    • Sysmex-Inostics, Inc.
    • Tempus
    • VolitionRx

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us